Yoshiki Amuro

872 total citations
52 papers, 735 citations indexed

About

Yoshiki Amuro is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Yoshiki Amuro has authored 52 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 10 papers in Hepatology. Recurrent topics in Yoshiki Amuro's work include Drug Transport and Resistance Mechanisms (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Yoshiki Amuro is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Yoshiki Amuro collaborates with scholars based in Japan, China and United States. Yoshiki Amuro's co-authors include Kazuya Higashino, Toshikazu Hada, Noboru Ueki, Hiroyasu Imanishi, Tatsuhiko N. Ikeda, Jidong Cheng, Shinsuke Tamura, Yuichi Yamamura, Kiyohisa Uchida and Masakazu Adachi and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Cancer.

In The Last Decade

Yoshiki Amuro

50 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiki Amuro Japan 17 341 222 108 104 96 52 735
Rainer N. Zahlten United States 17 343 1.0× 99 0.4× 116 1.1× 27 0.3× 77 0.8× 27 794
Masayoshi Horimoto Japan 14 637 1.9× 213 1.0× 170 1.6× 42 0.4× 64 0.7× 33 1.0k
Lucia Daino Italy 25 919 2.7× 246 1.1× 165 1.5× 38 0.4× 113 1.2× 42 1.4k
Laura M. López‐Sánchez Spain 19 489 1.4× 187 0.8× 197 1.8× 46 0.4× 82 0.9× 34 1.1k
Jing Qi China 17 490 1.4× 221 1.0× 200 1.9× 58 0.6× 71 0.7× 40 996
Xijun Liu China 15 340 1.0× 136 0.6× 129 1.2× 32 0.3× 49 0.5× 27 629
Shinsuke Kanamura Japan 15 303 0.9× 193 0.9× 135 1.3× 17 0.2× 133 1.4× 88 789
C.-W. Chi Taiwan 17 240 0.7× 83 0.4× 76 0.7× 50 0.5× 28 0.3× 31 705
Sambasiva M. Rao United States 20 733 2.1× 317 1.4× 240 2.2× 154 1.5× 42 0.4× 26 1.4k
Hanning You United States 14 494 1.4× 282 1.3× 101 0.9× 39 0.4× 68 0.7× 18 1.1k

Countries citing papers authored by Yoshiki Amuro

Since Specialization
Citations

This map shows the geographic impact of Yoshiki Amuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiki Amuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiki Amuro more than expected).

Fields of papers citing papers by Yoshiki Amuro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiki Amuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiki Amuro. The network helps show where Yoshiki Amuro may publish in the future.

Co-authorship network of co-authors of Yoshiki Amuro

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiki Amuro. A scholar is included among the top collaborators of Yoshiki Amuro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiki Amuro. Yoshiki Amuro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jidong, Hiroyasu Imanishi, Yoshiki Amuro, & Toshikazu Hada. (2002). NS‐398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. International Journal of Cancer. 99(5). 755–761. 66 indexed citations
2.
Ueki, Noboru, Tomohiro Taguchi, Masayuki Takahashi, et al.. (2000). Inhibition of hyaluronan synthesis by vesnarinone in cultured human myofibroblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1495(2). 160–167. 18 indexed citations
3.
Amuro, Yoshiki, et al.. (1999). Plasma levels of pipecolic acid, both l- and d-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy. Clinica Chimica Acta. 287(1-2). 99–109. 24 indexed citations
4.
Ueki, Noboru, Hisako Yamamura, Katsuhito Takahashi, et al.. (1998). Induction of calponin-h1 by transforming growth factor-β1 in cultured human Ito cells, LI90. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1403(1). 28–36. 27 indexed citations
5.
Hada, Toshikazu, Suguru Akamatsu, Shin Yazawa, et al.. (1995). Increased plasma ? (1 ? 3)-l-fucosyltransferase activities in patients with hepatocellular carcinoma. Glycoconjugate Journal. 12(5). 627–631. 10 indexed citations
6.
Hayashi, Nobuki, Yoshinobu Matsuda, Yoshihide Asano, et al.. (1994). An autopsy case of cholangiocellular carcinoma associated with HCV antibody-positive liver cirrhosis.. Kanzo. 35(4). 309–313. 1 indexed citations
7.
Tamura, Toshihide, et al.. (1994). Δ22‐β‐Muricholic acid in monoassociated rats and conventional ratsacid in monoassociated rats and conventional rats. Lipids. 29(4). 289–296. 14 indexed citations
8.
Matsuda, Yoshinobu, Yoshiki Amuro, Toshikazu Hada, et al.. (1994). Aspartate aminotransferase-linked immunoglobulin complexes in serum of a patient with primary biliary cirrhosis. Journal of Gastroenterology. 29(2). 218–222. 6 indexed citations
9.
10.
Ueki, Noboru, et al.. (1993). Potentiation of Metastatic Capacity by Transforming Growth Factor‐β1 Gene Transfection. Japanese Journal of Cancer Research. 84(6). 589–593. 25 indexed citations
11.
Hada, Toshikazu, Yuzo Ichimori, Hiroyasu Imanishi, et al.. (1992). Establishment of an Enzyme Immunoassay Using Monoclonal Antibody (HG1‐219) and Its Application for the Diagnosis of Hepatocellular Carcinoma. Japanese Journal of Cancer Research. 83(12). 1366–1372. 1 indexed citations
12.
Ohe, Yasuo, Tomoyoshi Nishino, Sadahito Shin, et al.. (1990). Monoclonal Antibody to Pseudouridine Used to Develop a Radioimmunoassay. Journal of Immunoassay. 11(4). 459–475. 2 indexed citations
13.
Higashino, Kazuya, Hiroyasu Imanishi, Yoshiki Amuro, et al.. (1990). Purification and some properties of the fast migrating alkaline phosphatase in FL-amnion cells (the Kasahara isoenzyme) and its cDNA cloning. Clinica Chimica Acta. 186(2). 151–164. 13 indexed citations
14.
Amuro, Yoshiki, et al.. (1989). Reduction of 7-ketolithocholic acid by human liver enzyme preparations in vitro. American Journal of Physiology-Gastrointestinal and Liver Physiology. 256(1). G67–G71. 8 indexed citations
15.
Amuro, Yoshiki, Hiroko Nakaoka, Tetsuo Yamamoto, et al.. (1988). Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. Clinica Chimica Acta. 178(2). 151–158. 25 indexed citations
16.
Amuro, Yoshiki, et al.. (1988). Rapid high-performance liquid chromatography for pseudouridine assay in serum and urine. Clinica Chimica Acta. 172(1). 117–122. 4 indexed citations
17.
Hada, Toshikazu, Tetsuya Yamamoto, Hiroyasu Imanishi, et al.. (1987). Novel Cholinesterase Expression in the HuH-7 Cell Line. Tumor Biology. 8(1). 3–8. 9 indexed citations
18.
Moriwaki, Yuji, et al.. (1987). Autoimmune hepatitis or hepatic involvement in SLE?. Gastroenterologia Japonica. 22(2). 222–227. 6 indexed citations
19.
Nakano, Takashi, et al.. (1985). [Glycosaminoglycan, computed tomography and gallium-67 scanning in malignant pleural mesothelioma].. PubMed. 23(4). 401–12. 1 indexed citations
20.
Amuro, Yoshiki, et al.. (1976). A clinico-pathological study on bone metastases in the autopsied cases with hepatocellular carcinoma.. Kanzo. 17(1). 47–53. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rainer N. Zahlten Breakdown of academic impact, for papers by Masayoshi Horimoto Breakdown of academic impact, for papers by Lucia Daino Breakdown of academic impact, for papers by Laura M. López‐Sánchez Breakdown of academic impact, for papers by Jing Qi Breakdown of academic impact, for papers by Xijun Liu Breakdown of academic impact, for papers by Shinsuke Kanamura Breakdown of academic impact, for papers by C.-W. Chi Breakdown of academic impact, for papers by Sambasiva M. Rao Breakdown of academic impact, for papers by Hanning You
Rankless by CCL
2026